| Aug 18 |
Questor: This biotech firm is profiting from an overlooked area of healthcare
|
| Aug 14 |
Insider Sale: Director Matthew Posard Sells 29,881 Shares of Halozyme Therapeutics Inc (HALO)
|
| Aug 14 |
Halozyme Therapeutics, Inc.: Significantly Undervalued Growth Based On Current Fundamentals
|
| Aug 7 |
Madrigal (MDGL) Tops on Q2 Earnings, NASH Drug Drives Top Line
|
| Aug 7 |
Halozyme's (HALO) Q2 Earnings & Sales Top Estimates, Stock Up
|
| Aug 7 |
Zacks.com featured highlights include Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare
|
| Aug 7 |
Halozyme Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 7 |
Halozyme Therapeutics, Inc. (HALO) Q2 2024 Earnings Call Transcript
|
| Aug 6 |
Compared to Estimates, Halozyme Therapeutics (HALO) Q2 Earnings: A Look at Key Metrics
|
| Aug 6 |
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates
|
